Fund Card

Fund Card

Nippon India Pharma Fund(G)

As on Jan-27-2020 change fund
158.51  up1.97 (1.26%)

fund objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

riskometer

Investors understand that their principal will be at high risk

5-Years History
financial year2015-20162016-20172017-20182018-20192019-2020
NAV in Rs (as on 27-Jan-2020)131.24135.25133.66151.74158.51
Net Assets(Rs Crores) (as on 27-Jan-2020) 1408.45 1444.86 1875.94 2687.68 2416.99
Scheme Returns(%)(Absolute)-6.323.13-2.1113.534.10
B'mark Returns(%)(Absolute)-13.741.71-14.457.46-0.29
Category Rank19/5848/5651/629/7344/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2019-2020-6.50-1.118.38NA
2018-20196.9510.70-5.501.47
2017-2018-4.950.1912.03-7.37
2016-20172.177.77-7.220.87
2015-2016-2.6414.72-2.43-12.47
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...10.74 
Divis Laboratories Ltd.9.55 
Cipla Ltd.9.50 
Dr. Reddys Laboratories Ltd.7.73 
Abbott India Ltd.7.48 
Lupin Ltd.7.27 
Syngene International Ltd.6.18 
Aurobindo Pharma Ltd.5.61 
Biocon Ltd.5.48 
Fortis Healthcare Ltd.5.46 

Category

Sector Funds

Launch Date

05-Jun-04

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

2,416.99

portfolio price to book value

4.71

investing style?

Mid Growth

fund manager?

Sailesh Raj Bhan,Kinjal Desai

inception date (regular plan)

05-Jun-04

expense ratio (regular plan) %

2.07

Alpha [%]

-0.03

Beta [%]

0.52

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs79.26
Hospital & Healthcare Services13.68
Miscellaneous6.63

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Nippon India Pharma Fund(G)Mid-Growth 05-Jun-20042,416.991.414.619.324.616.064.0914.2219.30BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Mid-Growth 28-Dec-2015166.082.065.968.6811.023.87NANA-0.64BUYSIP
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-2005394.610.955.5610.905.871.050.1111.7716.30BUYSIP
SBI Healthcare Opp Fund-Reg(G)Mid-Growth 14-Jul-1999926.471.575.8910.603.49-1.810.1713.9613.99BUYSIP
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-2018243.422.309.5514.6517.31NANANA15.82BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Mid-Growth 02-Jul-2018366.911.096.5110.8811.76NANANA9.82BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Mid-Growth 13-Jul-20181,286.901.125.5311.5910.46NANANA5.62BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Mid-Growth 10-Jul-2019171.461.996.619.08NANANANA12.90BUYSIP
IDBI Healthcare Fund-Reg(G)Mid-Growth 28-Feb-201931.321.474.448.55NANANANA10.50BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974